Neoadjuvant Therapy for Early Rectal Cancer: Organ Preservation
- Here's a breakdown of the provided text,focusing on the key facts and summarizing the study discussed:
- Main Topic: Total Neoadjuvant Therapy (TNT) as an alternative to surgery for Stage I Rectal Cancer.
- * High Response & Preservation: TNT achieved high complete response and organ preservation rates in patients with Stage I rectal cancer.
Here’s a breakdown of the provided text,focusing on the key facts and summarizing the study discussed:
Main Topic: Total Neoadjuvant Therapy (TNT) as an alternative to surgery for Stage I Rectal Cancer.
Key Findings:
* High Response & Preservation: TNT achieved high complete response and organ preservation rates in patients with Stage I rectal cancer.
* Organ Preservation: TNT may be a viable option for patients who want to avoid a permanent stoma (a surgically created opening in the abdomen for waste removal), especially those with low-lying tumors.
* Improved Outcomes: TNT shows promise in enhancing local response, reducing the risk of distant metastases, and possibly benefiting patients with locally advanced colon cancer.
Study Details:
* Participants: Patients with Stage I Rectal Cancer (S1RC) who declined total mesorectal excision (TME).
* Timeframe: Data collected between 2015 and 2023.
* Groups:
* Group 1: Patients with partial response after chemoradiation, followed by consolidation chemotherapy.
* Group 2: Patients who underwent transanal full-thickness local excision of rectal lesions, confirmed as S1RC, but declined further surgery.
* Outcomes Measured: Complete clinical response, organ preservation rates, recurrence rates, and metastasis rates.
Context & Background:
* Neoadjuvant therapy (treatment before surgery) is becoming more important in treating early-stage colorectal cancer.
* Traditional treatments (radiotherapy,chemoradiotherapy) control local disease but have limited impact on systemic relapse.
* TNT aims to improve both local and systemic outcomes.
Source:
* The information is based on a study published in Langenbeck’s Archives of Surgery (https://link.springer.com/article/10.1007/s00423-025-03895-2#Sec6).
In essence, the article highlights a potentially less invasive treatment option (TNT) for early-stage rectal cancer that could help patients avoid major surgery and maintain organ function.